210 related articles for article (PubMed ID: 19605601)
1. The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus.
Postma MJ; de Zeeuw D
Nephrol Dial Transplant; 2009 Oct; 24(10):2975-83. PubMed ID: 19605601
[No Abstract] [Full Text] [Related]
2. Prevention of end-stage renal disease due to type 2 diabetes.
Hostetter TH
N Engl J Med; 2001 Sep; 345(12):910-2. PubMed ID: 11565525
[No Abstract] [Full Text] [Related]
3. [The NEPHRODIAB2 randomized trial].
Villar E; Lièvre M; Labeeuw M; Pouteil-Noble C
Nephrologie; 2003; 24(6):317-9. PubMed ID: 14584299
[No Abstract] [Full Text] [Related]
4. Diabetic kidney disease: act now or pay later.
Atkins RC; Zimmet P
J Hypertens; 2010 Feb; 28(2):408-10. PubMed ID: 20087106
[No Abstract] [Full Text] [Related]
5. Diabetic kidney disease: act now or pay later.
Atkins RC; Zimmet P
Acta Diabetol; 2010 Mar; 47(1):1-4. PubMed ID: 20099002
[No Abstract] [Full Text] [Related]
6. The CARI guidelines. Prevention and management of chronic kidney disease in type 2 diabetes.
Chadban S; Howell M; Twigg S; Thomas M; Jerums G; Cass A; Campbell D; Nicholls K; Tong A; Mangos G; Stack A; MacIsaac RJ; Girgis S; Colagiuri R; Colagiuri S; Craig J;
Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S162-94. PubMed ID: 20591029
[No Abstract] [Full Text] [Related]
7. The CARI guidelines. Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetes.
Chadban S; Howell M; Twigg S; Thomas M; Jerums G; Cass A; Campbell D; Nicholls K; Tong A; Mangos G; Stack A; MacIsaac RJ; Girgis S; Colagiuri R; Colagiuri S; Craig J;
Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S195-203. PubMed ID: 20591031
[No Abstract] [Full Text] [Related]
8. Microalbuminuria and mortality in type 2 diabetes.
Strayer SM
J Fam Pract; 1998 Aug; 47(2):89-90. PubMed ID: 9722786
[No Abstract] [Full Text] [Related]
9. ACE inhibition in diabetic patients. Economic implications.
Rodby RA; Lewis EJ
Pharmacoeconomics; 1996 Oct; 10(4):315-20. PubMed ID: 10163576
[No Abstract] [Full Text] [Related]
10. Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuria.
Postma MJ; Boersma C; Gansevoort RT
Nephrol Dial Transplant; 2008 Apr; 23(4):1103-6. PubMed ID: 17210586
[No Abstract] [Full Text] [Related]
11. The diabetic patient with renal failure.
Ritz E; Schömig M
Nefrologia; 2000; 20 Suppl 3():16-24. PubMed ID: 10835873
[No Abstract] [Full Text] [Related]
12. [Angiotensin II antagonist also protects the kidneys. 2 dialysis-free years for diabetics].
MMW Fortschr Med; 2001 Oct; 143(43):50. PubMed ID: 11715881
[No Abstract] [Full Text] [Related]
13. Nephrologists sans frontières: preventing chronic kidney disease on a shoestring.
Mani MK
Kidney Int; 2006 Sep; 70(5):821-3. PubMed ID: 16929327
[No Abstract] [Full Text] [Related]
14. Preventable kidney failure: the cost of diabetes neglect?
Endre ZH; Beaven D; Buttimore A
N Z Med J; 2006 Dec; 119(1246):U2338. PubMed ID: 17151712
[TBL] [Abstract][Full Text] [Related]
15. [Low carbohydrate diet slowed down the progression of renal insufficiency in type 2 diabetes. A case--difficult to draw conclusions].
Vesti-Nielsen J; Westerlund P; Bygren P
Lakartidningen; 2008 Jul 23-Aug 5; 105(30-31):2094-7. PubMed ID: 18751447
[No Abstract] [Full Text] [Related]
16. Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes: response to Shultis et al.
Varon FN
Diabetes Care; 2007 Dec; 30(12):e138; author reply e139. PubMed ID: 18042747
[No Abstract] [Full Text] [Related]
17. End-stage renal disease in people with type 2 diabetes: systemic manifestations and exercise implications.
Evans N; Forsyth E
Phys Ther; 2004 May; 84(5):454-63. PubMed ID: 15113278
[No Abstract] [Full Text] [Related]
18. Protein restriction and renal failure in diabetes mellitus.
Parving HH
N Engl J Med; 1991 Jun; 324(24):1743-4. PubMed ID: 2034255
[No Abstract] [Full Text] [Related]
19. [Increasing number of dialysis-requiring patients with diabetic nephropathies. Better diabetes control and antihypertensive treatment can counteract the trend].
Kurkus J; Schön S; Prütz KG; Torffvit O
Lakartidningen; 2005 May 2-15; 102(18-19):1420-3. PubMed ID: 15929425
[No Abstract] [Full Text] [Related]
20. [Current guidelines for the prevention and treatment of diabetic nephropathy. International Diabetes Federation].
Bilo HJ
Ned Tijdschr Geneeskd; 1995 Sep; 139(36):1847-9. PubMed ID: 7477510
[No Abstract] [Full Text] [Related]
[Next] [New Search]
